Client & Alumni News

Ben Franklin Client Cernostics Raises $1.4 Million in Series B Round

Cernostics’ Series B funding will further develop a breakthrough diagnostic platform, producing comprehensive risk prediction for the development of esophageal cancer in patients with Barrett’s Esophagus. Read more.